SAR443820 clinical trials

A Phase 1, open-label, single-center study to determine the absorption, distribution, metabolism, and excretion of a single oral dose of SAR443820 containing microtracer [14C]-SAR443820 in healthy male participants

This study is looking at how a new drug called SAR443820 moves through the body in healthy men. It aims to understand how the body absorbs, uses, and gets rid of the drug, which could one day help people with ALS.